Cardiology

In data presented at AAO, investigators examine the impact of anti-VEGF injections on ocular hypertension.

In data presented at AAO 2020, researchers discover new methods for detecting different underlying conditions.

Presented at AHA 2020, results of GALACTIC-HF suggest omecamtiv mecarbil was associated with an 8% reduction in risk for worsening heart failure.

An analysis of blood samples from more than 19k women offers greater insight into the relationship between premature menopause and cardiovascular disease risk in postmenopausal women.

With the spotlight on the issue shining greater than ever in the US, the American Heart Association and cardiologists have been taking aim at addressing structural racism and its impact on health care.

SimpleSENSE is a first-of-its-kind cloth-based diagnostic platform that can capture more than 100 million data points per patient per day across cardiac, pulmonary, and circulatory biomarkers.

An analysis of CDC data presented at AHA Scientific Sessions 2020 suggests rates of high blood pressure complications during pregnancy nearly doubled during a period lasting from 2008-2017.

Analysis of data from the 5000-patient Look AHEAD Trial details the varying effects of changes in lean mass, fat mass, and waist circumference, respectively, on risk of heart failure and myocardial infarctions in patients with type 2 diabetes.

Older patients benefit greater from LDL-cholesterol lowering medications.

An analysis of data from 3 major health studies details associations between anti-inflammatory foods and lower risk of stroke and heart disease.

Analysis of data from the SUSTAIN program suggests adverse gastrointestinal events contributed little to superior weight loss seen with semaglutide versus other GLP-1 receptor agonists.

An analysis of patients presenting to more than a dozen stroke centers in England and Scotland gives physicians an updated look at trends and outcomes of stroke patients with COVID-19 compared to their counterparts without the disease.

The therapy was previously approved to reduce the risk of cardiovascular death, MI, and stroke in patients with ACS or previous MI.

Learn more about the latest indication for ticagrelor from the FDA and check out an exclusive interview from S. Claiborne Johnston, MD, PhD, on results of the pivotal THALES trial.

Collaborative Care: Technology’s Evolving Role in Cardiometabolic Health is a 3-part feature series examining the evolution of technology in the management of patients with cardiometabolic diseases, such as cardiovascular disease and diabetes.

Dr. Melissa Young details the evolution of technology in diabetes management from the perspective of a practicing endocrinologist.

A practicing healthcare attorney offers advice and perspective on the potential role of remote patient monitoring in the care of patients with cardiovascular disease.